ECONSULT HEALTH LIMITED

Active London
39 employees website.com
Healthcare and wellbeing
E

ECONSULT HEALTH LIMITED

Founded 10 May 2011 Active London, England 39 employees website.com
Healthcare and wellbeing

Previous Company Names

HURLEY INNOVATIONS LIMITED 10 May 2011 — 24 May 2018
Accounts Submitted 28 Nov 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 26 Nov 2025 Next due 10 Dec 2026 7 months remaining
Net assets £599K £2M 2024 year on year
Total assets £3M £3M 2024 year on year
Total Liabilities £2M £5M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

13th Floor, 21-24 Millbank Tower Millbank London SW1P 4QP England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ECONSULT HEALTH LIMITED (07628675), an active healthcare and wellbeing company based in London, England. Incorporated 10 May 2011. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£219.25k

Decreased by £680.75k (-76%)

Net Assets

£599.07k

Increased by £2.09M (+140%)

Total Liabilities

£1.95M

Decreased by £4.82M (-71%)

Turnover

N/A

Employees

39

Decreased by 33 (-46%)

Debt Ratio

76%

Decreased by 52 (-41%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Oct 2020Strategic Investment, Series A
Investor 2Feb 2021Series A

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 3,094,346 Shares £63k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Apr 2024666,868£66.687£0
5 Apr 202223,359£15k£0.642
5 Apr 2022338,541£33.854£0
5 Apr 202223,359£15k£0.642
20 May 20212,022,080£202.208£0

Officers

Officers

1 active 2 resigned
Status
Danoosh VahdatDirectorBritishUnited Kingdom4116 Sept 2024Active

Shareholders

Shareholders (66)

Huma Therapeutics Limited
66.8%
22,970,152
Huma Therapeutics Limited
16.1%
5,536,359

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Active
Notified 16 Sept 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Danoosh Vahdat

Ceased 16 Sept 2024

Ceased

Murray Ellender

Ceased 10 May 2020

Ceased

Ben Shankland

Ceased 16 Sept 2024

Ceased

Group Structure

Group Structure

ECONSULT HEALTH LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Apr 2026IncorporationMemorandum Articles
18 Mar 2026ResolutionResolutions
12 Mar 2026OfficersTermination of Murray Ellender as director on 2026-02-26
28 Nov 2025AccountsAnnual accounts made up to 2024-12-31
28 Nov 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
8 Apr 2026 Incorporation

Memorandum Articles

18 Mar 2026 Resolution

Resolutions

12 Mar 2026 Officers

Termination of Murray Ellender as director on 2026-02-26

28 Nov 2025 Accounts

Annual accounts made up to 2024-12-31

28 Nov 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

Recent Activity

Latest Activity

Memorandum Articles

1 weeks ago on 8 Apr 2026

Resolutions

1 months ago on 18 Mar 2026

Termination of Murray Ellender as director on 2026-02-26

1 months ago on 12 Mar 2026

Annual accounts made up to 2024-12-31

4 months ago on 28 Nov 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

4 months ago on 28 Nov 2025